Health-Chem Corp
OTC:HCLC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Health-Chem Corp
OTC:HCLC
|
US |
|
Itera ASA
OSE:ITERA
|
NO |
|
R
|
Royal Century Resources Holdings Ltd
HKEX:8125
|
HK |
|
A
|
Asia Properties Inc
OTC:ASPZ
|
US |
|
B
|
Banco de Sabadell SA
XBER:BDSB
|
ES |
|
Similarweb Ltd
NYSE:SMWB
|
IL |
|
Vardhman Polytex Ltd
NSE:VARDMNPOLY
|
IN |
Health-Chem Corp
Health-Chem Corp. develops, manufactures and markets transdermal drug delivery systems. The company is headquartered in New York City, New York and currently employs 206 full-time employees. Transderm owns 98.5% of Hercon Laboratories Corporation, which develops and manufactures controlled release products for the pharmaceutical industry, at Transderm's Pennsylvania facility, to deliver a variety of drugs topically or transdermally. The firm has manufactured over-the-counter pharmaceutical and cosmetic products that are used to clean facial pores. These deep cleansing facial pore strips are designed to remove clogged dirt, oil and blackheads from the nose, chin, forehead and anywhere else on the face that needs deep cleaning. In addition to its nitroglycerin transdermal products, the Company is also developing transdermal products for hormone replacement therapies.
Health-Chem Corp. develops, manufactures and markets transdermal drug delivery systems. The company is headquartered in New York City, New York and currently employs 206 full-time employees. Transderm owns 98.5% of Hercon Laboratories Corporation, which develops and manufactures controlled release products for the pharmaceutical industry, at Transderm's Pennsylvania facility, to deliver a variety of drugs topically or transdermally. The firm has manufactured over-the-counter pharmaceutical and cosmetic products that are used to clean facial pores. These deep cleansing facial pore strips are designed to remove clogged dirt, oil and blackheads from the nose, chin, forehead and anywhere else on the face that needs deep cleaning. In addition to its nitroglycerin transdermal products, the Company is also developing transdermal products for hormone replacement therapies.
